Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.24M Buy
4,867
+213
+5% +$49.6K 0.39% 63
2026
Q1
$1.14M Buy
4,654
+137
+3% +$31.9K 0.4% 61
2025
Q4
$935K Sell
4,517
-826
-15% -$163K 0.33% 68
2025
Q3
$991K Sell
5,343
-42
-0.8% -$7.2K 0.35% 64
2025
Q2
$823K Sell
5,385
-890
-14% -$137K 0.31% 72
2025
Q1
$1.04M Buy
6,275
+13
+0.2% +$2.03K 0.43% 59
2024
Q4
$906K Buy
6,262
+208
+3% +$32.2K 0.37% 66
2024
Q3
$981K Buy
6,054
+12
+0.2% +$1.91K 0.41% 61
2024
Q2
$883K Buy
6,042
+14
+0.2% +$2.08K 0.4% 64
2024
Q1
$954K Sell
6,028
-106
-2% -$16.9K 0.43% 61
2023
Q4
$962K Sell
6,134
-582
-9% -$89.2K 0.47% 57
2023
Q3
$1.05M Sell
6,716
-810
-11% -$134K 0.55% 51
2023
Q2
$1.25M Sell
7,526
-112
-1% -$18.1K 0.65% 44
2023
Q1
$1.18M Sell
7,638
-41
-0.5% -$6.62K 0.62% 46
2022
Q4
$1.36M Sell
7,679
-7,633
-50% -$1.32M 0.72% 43
2022
Q3
$2.5M Buy
15,312
+7,321
+92% +$1.24M 0.74% 35
2022
Q2
$1.42M Sell
7,991
-20
-0.2% -$3.56K 0.69% 37
2022
Q1
$1.42M Sell
8,011
-298
-4% -$50.7K 0.6% 42
2021
Q4
$1.42M Sell
8,309
-137
-2% -$22.4K 0.58% 42
2021
Q3
$1.36M Sell
8,446
-22
-0.3% -$3.75K 0.62% 36
2021
Q2
$1.4M Buy
8,468
+46
+0.5% +$7.62K 0.64% 36
2021
Q1
$1.38M Sell
8,422
-35
-0.4% -$5.66K 0.67% 36
2020
Q4
$1.33M Sell
8,457
-36
-0.4% -$5.31K 0.71% 39
2020
Q3
$1.26M Buy
8,493
+14
+0.2% +$2.07K 0.75% 40
2020
Q2
$1.19M Buy
8,479
+117
+1% +$17.1K 0.7% 44
2020
Q1
$1.1M Buy
8,362
+223
+3% +$31.6K 0.79% 40
2019
Q4
$1.19M Buy
8,139
+160
+2% +$21.7K 0.8% 45
2019
Q3
$1.03M Sell
7,979
-37
-0.5% -$4.88K 0.75% 43
2019
Q2
$1.12M Sell
8,016
-1,511
-16% -$209K 0.8% 41
2019
Q1
$1.33M Buy
9,527
+18
+0.2% +$2.41K 0.96% 37
2018
Q4
$1.23M Sell
9,509
-6,716
-41% -$937K 1.04% 34
2018
Q3
$568 Buy
16,225
+26
+0.2% +$3.46K 0.32% 52
2018
Q2
$1.97M Sell
16,199
-571
-3% -$71.2K 1.46% 18
2018
Q1
$2.15M Sell
16,770
-2,383
-12% -$322K 1.6% 18
2017
Q4
$2.68M Buy
19,153
+3,489
+22% +$486K 1.98% 12
2017
Q3
$2.04M Buy
15,664
+799
+5% +$106K 1.74% 16
2017
Q2
$1.97M Buy
14,865
+426
+3% +$54.3K 1.79% 15
2017
Q1
$1.8M Sell
14,439
-2,523
-15% -$301K 1.73% 16
2016
Q4
$1.95M Sell
16,962
-7,579
-31% -$875K 1.91% 13
2016
Q3
$2.9M Buy
24,541
+7,471
+44% +$906K 1.64% 16
2016
Q2
$2.07M Sell
17,070
-6,925
-29% -$787K 2.06% 9
2016
Q1
$2.46M Buy
23,995
+7,319
+44% +$758K 1.61% 17
2015
Q4
$1.71M Buy
16,676
+217
+1% +$21.8K 2.06% 9
2015
Q3
$1.53M Sell
16,459
-662
-4% -$64K 2.01% 9
2015
Q2
$1.67M Sell
17,121
-216
-1% -$21.6K 2.01% 9
2015
Q1
$1.75M Sell
17,337
-156
-0.9% -$15.9K 1.92% 10
2014
Q4
$1.83M Buy
+17,493
New +$1.84M 2.1% 10

Other funds holding JNJ

Investment Partners's JNJ Position: Q2 2026 in Review

Investment Partners increased its Johnson & Johnson (JNJ) stake by 4.6% in Q2 2026, buying an estimated $49.6K and bringing the position to 4,867 shares worth $1.24M. The position accounts for 0.39% of the portfolio, ranked #63.

Investment Partners first reported a position in JNJ in Q4 2014 and has held it in 47 quarters since. The position peaked at $2.9M in Q3 2016. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Investment Partners held 4,867 shares of Johnson & Johnson worth $1.24M as of Q2 2026.
  • Investment Partners bought 213 Johnson & Johnson shares in Q2 2026, an estimated $49.6K.
  • Johnson & Johnson made up 0.39% of Investment Partners's portfolio in Q2 2026, its #63 holding.
  • Investment Partners first reported a position in Johnson & Johnson in Q4 2014 and has held it in 47 quarters since.
  • Investment Partners's Johnson & Johnson position peaked at $2.9M in Q3 2016.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Investment Partners's 13F filing for Q2 2026, filed 4 Aug 2026.